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Abstract 
 
Repeat cardiac surgery in patients with a previous sternotomy is associated with 
significant morbidity and mortality. While transcatheter aortic valve 
implantation in high risk surgical patients is now well established [1,2], 
experience with transcatheter mitral valve replacement is still at an early stage. 
Although many successful reports of transcatheter mitral valve replacements 
now exist, the predominant approach has been via a transapical approach[3]. It 
is likely that, as with the evolution of favoured access routes for transcatheter 
aortic therapies, future directions for transcatheter mitral valves will focus on 
smaller delivery systems favouring the transvenous transseptal approach where 
possible. We present the first reported case of combined transseptal para-ring 
leak closure followed by transcatheter mitral valve implantation using a 12/5 
mm Amplatzer III vascular plug and a 29 mm SAPIEN 3 valve. 
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Simultaneous Transseptal Para-Ring Leak Closure and Transcatheter 
Mitral Valve Implantation for the Treatment of Surgical Mitral Repair 
Failure 
 
We describe a successful case of combined transseptal para-ring leak closure and 
transcatheter  mitral valve implantation (valve-in-ring) for the treatment of  a 
symptomatic 57-year-old man with a failed mitral valve repair and annuloplasty 
ring 18 months prior. At the end of the procedure, transoesophageal 
echocardiography confirmed that the valve was in a good position with no 
significant residual mitral regurgitation. The patient was discharged home the 
following day. This is the first reported case of combined transseptal para-ring 
leak closure followed by transcatheter mitral valve implantation with an 
Edwards SAPIEN 3 valve. 
 
Introduction 
 
Repeat cardiac surgery in patients with a previous sternotomy is associated with 
significant morbidity and mortality. While transcatheter aortic valve 
implantation in high risk surgical patients is now well established [1,2], 
experience with transcatheter mitral valve replacement is still at an early stage. 
Although many successful reports of transcatheter mitral valve replacements 
now exist, the predominant approach has been via a transapical approach[3]. It 
is likely that, as with the evolution of favoured access routes for transcatheter 
aortic therapies, future directions for transcatheter mitral valves will focus on 
smaller delivery systems favouring the transvenous transseptal approach where 
possible. We present the first reported case of combined transseptal para-ring 
leak closure followed by transcatheter mitral valve implantation using a 12/5 
mm Amplatzer III vascular plug and a 29 mm SAPIEN 3 valve. 
 
Case Report 
 
 A 57-year-old man presented with progressive dyspnoea (New York Heart 
Association class III). The patient had undergone mitral valve repair with a 30 
mm annuloplasty ring and single coronary artery bypass 18 months prior, in 
2015. Other medical background included a previous inferior myocardial infarct 
and aneurysm, ventricular tachycardia with dual chamber defibrillator insertion 
and a previous embolic stroke complicating coronary angiography in 2015. 
 
  Echocardiography demonstrated moderate left ventricular impairment with an 
inferior aneurysm and an ejection fraction of 35%. There was severe mitral 
regurgitation (MR) secondary to a posteriorly located para-ring leak (Figure 1). 
Coronary angiography revealed patent bypass grafts with no significant disease. 
His operative risk was deemed to be high with a Society of Thoracic Surgeons 
(STS) score of 19.98%. The consensus of our multidisciplinary heart team 
meeting was to proceed with a combined transseptal para-ring leak closure and 
transcatheter approach. 
 
 The procedure was performed in a hybrid catheter laboratory and the cardiac 
surgeons were available for redo surgery as a bailout strategy if required. The 
procedure was performed under general anaesthesia with fluoroscopic and 
transoesophageal echocardiography (TOE) guidance. Fluoroscopy-
echocardiography fusion imaging was facilitated by the EchoNavigator®-system 
(Philips Healthcare, Best, the Netherlands) allowing merging of 
echocardiographic and fluoroscopic images on the same display in real-time 
(Figure 2). No contrast was used. The initial strategy was to close the para-ring 
leak first and then review the degree of residual regurgitation. A transcatheter 
valve-in-ring implant would only be inserted if there remained significant 
residual regurgitation.  
 
 The right femoral vein was punctured under ultrasound guidance and a 6 Fr 
sheath was inserted. A temporary pacing wire was inserted via a 6 Fr sheath in 
the left femoral vein. Using a J-wire the right femoral sheath was exchanged for 
an 8.5 Fr SLO sheath and septal puncture was performed using a Brokenbrough 
needle. A BMW coronary guidewire was advanced through the Brokenbrough 
needle into the left upper pulmonary vein. After heparinisation, a double length 
0.025-inch J-tipped guidewire (Terumo Glidewire, Terumo Medical Corp., 
Somerset, NJ, USA ) was used inside a 6Fr internal mammary (IMA) diagnostic 
catheter to cross the defect using EchoNavigator. To provide more support, the 
Terumo glidewire was externalised around the left ventricular apex and across 
the aortic valve into the descending aorta. The IMA catheter was advanced over 
this and used to exchange for a 260 cm 0.035-inch J-tipped Amplatzer Super Stiff 
guidewire (AGA Medical Corp., Plymouth, MN, USA). The sheath was then 
exchanged for a destination catheter and a 12/5 mm Amplatzer vascular plug 
(AVP) III (St. Jude Medical) was deployed after confirmation of proper device 
positioning by TOE. Subsequent TOE showed that the para-ring leak was sealed 
(Figure 3). As there was now a residual, centrally directed, regurgitant jet due to 
failure of co-aptation of the anterior mitral valve leaflet on the vascular plug the 
decision was made to proceed with insertion of a transcatheter valve.  A 29 mm 
valve implant size was selected based on the 30 mm annular ring. 
 
  Again the Terumo glidewire was passed into the descending aorta with an IM 
catheter and exchanged for the Amplatzer Super Stiff wire. This was used to 
exchange to a 16 French E Sheath (Edwards Lifesciences , Irvine , CA). A 29 mm 
SAPIEN 3 valve was positioned and deployed during rapid ventricular pacing. 
 
Post-deployment TOE demonstrated an excellent valve position with no residual 
MR (Figure 4). We elected not to close the iatrogenic atrial septal defect as the 
shunt was small. 
 
 The patient was extubated in recovery and transferred to the coronary care unit 
for routine care. The patient was well and was discharged on the first 
postoperative day. Discharge transthoracic echocardiography showed only 
trivial MR. 
 
Discussion 
 
As seen in recent years with transcatheter aortic valve implantation, 
transcatheter mitral valve replacement has rapidly evolved to become one of the 
new frontiers in the field of interventional cardiology. Although it is still at an 
early stage it is likely that the number of patients with failed surgical mitral 
bioprostheses or mitral rings and prohibitive risk of a redo operation will 
continue to increase. Due to the challenging anatomy of the mitral valve and the 
wide variety of mitral pathology a variety of transcatheter approach options will 
always be required. The transapical approach has been used most frequently 
owing to the direct access and coaxiality with the mitral apparatus from the left 
ventricular apex. Alternative approaches include a transseptal approach  and an 
off-pump transatrial approach through an anterolateral minithoracotomy [4]. 
There are obvious advantages to the less invasive transseptal approach where 
feasible. Important complications of this approach include valve embolisation, 
left ventricular outflow tract obstruction, and catheter induced ventricular 
perforation. Other limitations to this approach are the size of the delivery 
sheaths through the septum and also the long-term management of iatrogenic 
septal defects(iASD). Despite the rapidly expanding number of left atrial 
transcatheter procedures performed via a transseptal approach, the optimal 
management strategy of postprocedural iASD is currently unknown [5]. 
 
  Accurate sizing of the mitral prosthesis can be challenging and it is important to 
emphasise that undersizing of the transcatheter implant can also lead to 
significant paravalvular regurgitation and the risk of haemolysis [6]. In this case 
performing the leak closure before implanting the valve may have several  
advantages. Firstly, if there is a good result from leak closure a transcatheter 
valve may be avoided. Secondly, it may be more difficult to cross the para-ring 
defect after transcatheter deployment. Kliger and colleagues described the 
complication of converting para-ring/extravalvular MR into severe intravalvular 
MR due to disruption of the mitral apparatus following Amplatzer vascular plug 
deployment [7]. We believe this is because the vascular plug may lead to failure 
of closure of the mitral valve leaflets as in our case. Therefore, a combined 
approach with an option to perform para-ring and transcatheter closure is likely 
to be important in this rapidly emerging field.  
 
Transseptal treatment of a degenerative surgical mitral repair with significant 
paravalvular regurgitation is feasible in high-risk patients with para-ring leak 
repair followed by valve-in-ring implantation if required during the same 
procedure.  
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Figure Legend 
 
Figure 1. Transoesophageal Echocardiography (TOE) showing A) The surgeon’s 
3D view of the mitral valve from the left atrial side showing a posteriorly located 
defect [arrow];  B) Severe paravalvular mitral regurgitation 
 
Figure 2. Using EchoNavigator Fluoroscopy Fusion Imaging simultaneous colour 
Doppler can be overlaid on the operator screen to help crossing the defect, which 
is reflected as a dot. 
 
Figure 3. A) Fluoroscopic Image of the vascular plug in relation to the 
annuloplasty ring; B) 3D TOE view of the vascular plug from the left ventricular 
side. Both views show a co-axial position. 
 
Figure 4. A) Positioning of the 29mm SAPIEN 3; B) Final result with deployed  
SAPIEN 3 valve and the occluder plug.  
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